At Market Issuance Sales AgreementNovavax Inc • October 2nd, 2012 • Biological products, (no disgnostic substances) • New York
Company FiledOctober 2nd, 2012 Industry JurisdictionNovavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV”), as follows: